Akutes Auftreten einer eosinophilen Dermatitis nach COVID-19-Impfung mit BNT162b2 (Comirnaty)

被引：0

作者：

Kabatas, A. S. ^{[1
]}

Gaetjen, F. ^{[1
]}

Schacht, V. ^{[1
]}

Kapp, A. ^{[1
]}

Wedi, B. ^{[1
]}

机构：

[1] Hannover Med Sch, Klin fur Dermatologie, Allergologie und Venerologie der, Hannover, Germany

来源：

ALLERGOLOGIE | 2023年 / 46卷 / 02期

关键词：

COVID-19; vaccination; dermatitis; eosinophilic; granulocytes;

D O I：

10.5414/ALX02356

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

In the current time, the question about possible side effects of the COVID-19 immunization has a high priority, especially because booster vaccinations are being discussed, making the occurrence of side effects more likely. In order to better understand the latter, the compilation of the side effects that have occurred is indispensable. Therefore, we report a new case from our dermatological university outpatient clinic at Hannover Medical School, which sheds light on a possible link between active immunization to prevent COVID-19 disease caused by SARS-CoV-2 and the role of eosinophilic granulocytes.

引用

页码：107 / 112

页数：6

共 50 条

[21] BNT162b2 mRNA COVID-19 Vaccine: First Approval
Lamb, Yvette N.
DRUGS, 2021, 81 (04) : 495 - 501
[22] Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine
Lopez-Valle, Alba
Falkenhain-Lopez, Daniel
Arranz, Celia R.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (07) : 891 - 892
[23] Erythema multiforme following COVID-19 vaccination (BNT162b2)
Wunderlich, K.
Dirschka, T.
HAUTARZT, 2022, 73 (01): : 68 - 70
[24] Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination
Ikediobi, Ogechi
Eichenfield, Dawn Z.
Barrio, Victoria R.
PEDIATRIC DERMATOLOGY, 2022, 39 (05) : 823 - 824
[25] Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
Klein, Nicola P.
Demarco, Maria
Fleming-Dutra, Katherine E.
Stockwell, Melissa S.
Kharbanda, Anupam B.
Gaglani, Manjusha
Rao, Suchitra
Lewis, Ned
Irving, Stephanie A.
Hartmann, Emily
Natarajan, Karthik
Dalton, Alexandra F.
Zerbo, Ousseny
DeSilva, Malini B.
Konatham, Deepika
Stenehjem, Edward
Rowley, Elizabeth A. K.
Ong, Toan C.
Grannis, Shaun J.
Sloan-Aagard, Chantel
Han, Jungmi
Verani, Jennifer R.
Raiyani, Chandni
Dascomb, Kristin
Reese, Sarah E.
Barron, Michelle A.
Fadel, William F.
Naleway, Allison L.
Nanez, Juan
Dickerson, Monica
Goddard, Kristin
Murthy, Kempapura
Grisel, Nancy
Weber, Zacharay A.
Dixon, Brian E.
Patel, Palak
Fireman, Bruce
Arndorfer, Julie
Valvi, Nimish R.
Griggs, Eric P.
Hallowell, Carly
Embi, Peter J.
Ball, Sarah W.
Thompson, Mark G.
Tenforde, Mark W.
Link-Gelles, Ruth
PEDIATRICS, 2023, 151 (05)
[26] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, Fernando P.
Thomas, Stephen J.
Kitchin, Nicholas
Absalon, Judith
Gurtman, Alejandra
Lockhart, Stephen
Perez, John L.
Perez Marc, Gonzalo
Moreira, Edson D.
Zerbini, Cristiano
Bailey, Ruth
Swanson, Kena A.
Roychoudhury, Satrajit
Koury, Kenneth
Li, Ping
Kalina, Warren V.
Cooper, David
Frenck, Robert W., Jr.
Hammitt, Laura L.
Tureci, Ozlem
Nell, Haylene
Schaefer, Axel
Unal, Serhat
Tresnan, Dina B.
Mather, Susan
Dormitzer, Philip R.
Sahin, Ugur
Jansen, Kathrin U.
Gruber, William C.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27): : 2603 - 2615
[27] Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
Dogan, Mustafa
Yilmaz, Berna
ACTA PHARMACEUTICA, 2023, 73 (02) : 257 - 268
[28] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Wang, Xiang
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1577 - 1578
[29] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
Tumminia, Andrea
Romano, Marcello
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 191 - 191
[30] BNT162b2 mRNA COVID-19 Vaccine: First Approval
Yvette N. Lamb
Drugs, 2021, 81 : 495 - 501

← 1 2 3 4 5 →